Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Gel-Tec certified

This article was originally published in The Tan Sheet

Executive Summary

Tishcon's Q-Gel dietary supplement line "meets label and safety claims," NSF Intenational announces July 24. Products include Q-Gel, Q-Gel Forte, Q-Gel Ultra and Q-Gel Mega. Other recent NSF certifications include Perrigo's manufacturing facilities for meeting GMP requirements, Arizona Nutritional Supplements' d-glucosamine HCl (1"The Tan Sheet" April 8, 2002, In Brief)...

You may also be interested in...

NSF certifies Perrigo

Private labeler receives GMP registration for Greenville, S.C. vitamin, nutritional supplement facilities under NSF Dietary Supplements Certification Program April 2. NNFA conducted plant audit at the Perrigo facility to verify compliance with GMPs; firm will undergo periodic audits to maintain the registration. Collaboration between NNFA, NSF began in November to allow for more affordable testing (1"The Tan Sheet" Nov. 19, 2001, p. 16). Other recent NSF certifications include Arizona Nutritional Supplements (for GMPs), WellAble Group's d-glucosamine HCl...

Ironwood Ends Phase III GERD Program, Will Cut 100 Jobs

The company has no development programs left in its R&D pipeline and will focus entirely on the commercialization of IBS drug Linzess while seeking late-stage assets from external sources.

FDA Finalizes Guidance On Blood Glucose Meters With Separate Documents For OTC, Rx Devices

The documents issued by the US agency on 29 September set slightly different accuracy standards, reflecting the increased fragility of hospital patients.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts